Oruka Therapeutics, Inc. (NASDAQ: ORKA) is catching the attention of investors with its promising pipeline of monoclonal antibody therapeutics targeting inflammatory and immunology (I&I) diseases. Headquartered in Menlo Park, California,..
Rapport Therapeutics, Inc. (NASDAQ: RAPP) is capturing investor attention with its impressive 84.56% potential upside, as evidenced by the latest analyst ratings. As a clinical-stage biopharmaceutical company, Rapport Therapeutics is..
AngioDynamics, Inc. (NASDAQ: ANGO), a notable player in the healthcare sector, has caught the attention of investors, not least because of its potential upside of over 92%, as per analyst..
Fortrea Holdings Inc. (NASDAQ: FTRE), a burgeoning player in the healthcare sector, specifically within the biotechnology industry, presents a multifaceted proposition to investors. With a market capitalization of $1.61 billion,..
Kamada Ltd. (NASDAQ: KMDA), a prominent player in the healthcare sector, is generating buzz among investors due to its compelling potential upside of 63.52%. As a specialist in plasma-derived protein..
The biotechnology sector often captures investor interest with its potential for groundbreaking medical innovations, and Autolus Therapeutics plc (NASDAQ: AUTL) is no exception. Headquartered in London, this clinical-stage biopharmaceutical company..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is making waves in the biotechnology sector, offering a tantalizing prospect for investors seeking high-growth opportunities in healthcare. With a market capitalization of $822.94 million,..
SIGA Technologies Inc. (NASDAQ: SIGA), a notable player in the healthcare sector, specializes in developing antiviral drugs. With a specific focus on health security, SIGA’s flagship product, TPOXX, is designed..
Investors have been keeping a keen eye on COMPASS Pathways Plc (NASDAQ: CMPS), a pioneering biotech firm at the forefront of mental health treatment innovation. With a market capitalization of..
Cross Country Healthcare, Inc. (NASDAQ: CCRN), a notable player in the healthcare staffing industry, is navigating a challenging landscape marked by fluctuating market conditions and evolving healthcare needs. As an..
Theravance Biopharma, Inc. (TBPH), a prominent player in the biotechnology sector, is capturing investor attention with its significant potential upside. With a market capitalization of approximately $963.79 million, this South..
